.jpg)
Singapore Biotech Brings New Cancer Drug to First Patient
After years of development in Singapore, a groundbreaking cancer treatment reached its first human patient in London, targeting a protein that's stumped scientists for three decades. Hummingbird Bioscience's HMBD-001 could change how we fight stubborn tumors.